FDA Registration of Your IVD laboratory Instrument
Posted by:
Patrick Widler
Published on:
Jul 5, 2017
Many providers of in vitro diagnostic (IVD) laboratory instruments successfully launch their lab instruments in Europe but are wary of bringing their product to the US market. One concern is the amount of effort required to comply with the regulatory requirements of the Food & Drugs Administration (FDA).
FDA registration categories
FDA registration classifies medical devices, including IVD laboratory instruments, into three categories depending on the risk associated with the product: Class I products bear a low risk (e.g., general laboratory equipment for a specific clinical use); Class II devices are higher risk products (e.g., lab instrumentation for clinical multiplex test systems); and Class III includes products with the highest risk, such as HPV detection systems. The level of regulatory control required increases with increasing risk. However, in many cases, particularly for Class I and specific Class II products, the level of effort required to achieve regulatory compliance is manageable.
FDA registration requirements
A crucial prerequisite for successful FDA registration is an established quality management system complying with the requirements of FDA 21 CFR part 820, also known as “QSR” (Quality System Regulation) or “GMP” (Good Manufacturing Practice). IVD laboratory instruments providers must define and implement adequate processes and develop and manufacture their products based on these GMP requirements to pass the FDA registration. This includes, amongst others, setting up the Design History File (DHF) with design and development planning, clearly defined product requirements, and planned and successfully completed verification and validation activities. Furthermore, the Device Master Record (DMR) with appropriate specifications and procedures for production and testing of the finished IVD laboratory instrument must be compiled and updated in case of changes. And, finally, the Device History Record (DHR) containing the production history of each batch, lot, or unit needs to be defined, completed, and maintained.
Many of the FDA’s QSR requirements are comparable with the provisions of the ISO 13485 standard, the most recent revision of which is more closely aligned with US regulations.
IVD laboratory instruments provider must submit a Premarket Notification for the US market
In addition to the requirements mentioned above, which are audited by the FDA with initial, pre-approval, or regular inspections, companies that want to market IVD Laboratory instruments in the US must submit a Premarket Notification (510(k)) for not exempted Class I or II products or a Premarket Approval (PMA) for Class III products and register the business (establishment registration) and the product (medical device listing) with the FDA.
How far away is the FDA registration of your IVD laboratory instrument?
The FDA registration of your lab instrument is not as far away as you think.
Go through this FREE CHECKLIST and consider if your product meets the expectations to pass the FDA registration of your IVD laboratory instrument in the US market successfully.
Touch Base with us
Related Posts
OEM family for all sample quality measurements
The quality control of samples is increasingly becoming a must-have, particularly for the so-called omics applications. Based on the intelligent sample handling of the ...
Technology Hub02/02/2024
Harnessing the Potential of Molecular Pathology
The rapidly evolving field of molecular pathology holds tremendous potential to advance therapeutic approaches in precision medicine. Cutting-edge technology and ...
Conferences & Events27/05/2024
5 Tips to Get Ready for the New EU In-Vitro Diagnostic Device Regulation
By end of 1998, the first European quality and safety requirements for in vitro diagnostic medical devices, the European Directive 98/79/EC (IVDD), stepped into effect. ...
Technology Hub19/07/2019
Why Data Analysis Workflows Belong to Modern Systems Engineering?
An Example of Fluidic Pressure Data from a DNA Sequencing Machine using simple PCA & Clustering.
Technology Hub21/03/2018
HSE•AG is now ISO 13485 certified
HSE•AG, a leading provider of laboratory automation, is proud to announce that it is now certified according to the ISO 13485:2016 standard (December 2017).
News & Updates09/02/2018
OEM component measures sample quality directly in PCR and NGS applications
With Colibri, we provide manufacturers of PCR and NGS solutions with an OEM component that allows them to integrate the measurement of concentration and purity of ...
News & Updates Technology Hub Conferences & Events07/07/2023
Expert Interview — How to Combine Biology and Engineering into Marketable Solutions
Laboratory automation development is a field best characterized by its interdisciplinarity. In addition to their expertise, engineers (be it mechanical, electronic, ...
Technology Hub17/06/2019
Liquid handling workflow innovation creates wow effect
Groundbreaking innovations take time and involve considerable project risks. We use the experience gained from countless automation projects to tackle new developments ...
Technology Hub22/03/2024
Day 2: BIO One-on-One Partnering™ at J.P. Morgan Healthcare Conference
HSE•AG attended the Biotechnology Innovation Organization (BIO) One-on-One Partnering™ at the J.P. Morgan Healthcare Conference in San Francisco, California.
Conferences & Events09/01/2018
Insights from the AMP 2024 Europe Congress
The AMP 2024 Europe Congress provided a valuable platform for experts to share their latest research and innovations in this dynamic field. We connected with attendees, ...
News & Updates Conferences & Events08/07/2024
PRESS RELEASE: PreON — Fully Automated Protein Sample Preparation for Mass Spectrometry
PreOmics GmbH, a developer of innovative technologies for mass spectrometry-based sample preparation, and HSE•AG, a leading provider of laboratory automation, are proud ...
News & Updates24/05/2019
At the Forefront of Oncology and Automated Liquid Biopsy
Liquid biopsy offers huge potential to transform cancer diagnosis, patient stratification, and treatment monitoring. By improving cancer screening and early detection, ...
Technology Hub15/04/2024
7 Secret Tricks to Optimize Emulsion PCR in the NGS Workflow
Next-generation sequencing (NGS) has revolutionized our understanding of life science, with more and more laboratories set to jump on the NGS bandwagon in the race to ...
Technology Hub13/09/2017
7 Smart Ways to Prevent Diagnostics System Development Projects from Failing
Diagnostic system development projects can be more prone to failure than you would think. Despite the eye-watering amounts of time and money that flow into these ...
Technology Hub25/06/2019
Farewell Mirjana — Special Agent Kozulic Is Retiring
Dedicated, fearless, tenacious, passionate – these are just a few attributes to describe my dear colleague and good friend Mirjana.
HSE Life25/06/2020